BMEM Cardiomyocyte Selection BMEM Cardiomyocyte Selection is a ready-to-use, serum-free formulation designed to selectively enrich cardiomyocytes from differentiated human iPSCs. Optimized for high purity and reproducibility, this medium creates a metabolic environment that supports the survival of cardiomyocytes while eliminating undifferentiated and non-cardiac cell types. With streamlined protocols and consistent performance, BMEM Cardiomyocyte Selection Media enables researchers to obtain highly enriched cardiomyocyte populations for downstream applications, including disease modeling, drug discovery, and regenerative medicine research. Key Features: - Robust cardiomyocyte enrichment from hiPSC-derived cultures - Serum-free, xeno-free formulation for consistency and scalability - Easy-to-use protocol requiring no specialized equipment - High reproducibility across multiple iPSC lines - Compatible with downstream functional assays and long-term culture
